Joanne Smith Farrell is COO, Oncology of bluebird bio, Inc.. Currently has a direct ownership of 20,609 shares of BLUE, which is worth approximately $175,176. The most recent transaction as insider was on Jan 06, 2021, when has been sold 1,287 shares (Common Stock) at a price of $45.11 per share, resulting in proceeds of $58,057. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K
0% 3M change
0% 12M change
Total Value Held $175,176

Joanne Smith-Farrell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2021
SELL
Open market or private sale
$58,057 $45.11 p/Share
1,287 Reduced 5.88%
20,609 Common Stock
Jan 05 2021
SELL
Open market or private sale
$1,888 $44.95 p/Share
42 Reduced 0.19%
21,896 Common Stock
Dec 02 2020
SELL
Open market or private sale
$1,761 $46.34 p/Share
38 Reduced 0.17%
21,938 Common Stock
Nov 02 2020
SELL
Open market or private sale
$1,983 $53.59 p/Share
37 Reduced 0.17%
21,976 Common Stock
Oct 02 2020
SELL
Open market or private sale
$2,005 $52.77 p/Share
38 Reduced 0.17%
22,013 Common Stock
JS

Joanne Smith Farrell

COO, Oncology
Cambridge, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE